Scholarlink

<p>Robot-assisted partial nephrectomy (RAPN) enables the management of complex localized renal masses while preserving renal function. However, the adoption of institutionalized same-day discharge (SDD) pathways remains limited. Herein, we report the safety and feasibility of SDD RAPN at an ambulatory surgery center (ASC) at our institution. We performed a retrospective observational study of patients who underwent SDD RAPN at a freestanding ASC at our institution during 2022–2025. Patients were eligible for the SDD pathway if they had a good performance status (ECOG 0–1), localized renal masses amenable to partial resection, reliable post-discharge communication, and travel time &lt; 2&#xa0;h from their residence to the hospital. A total of 63 patients underwent 65 SDD RAPNs at our ASC during 2022–2025. Patients had a median age at surgery of 62 years (interquartile range 51–71 years), and most were male (73%), non-Hispanic (63%), White (70%), and overweight (54%). Most patients had an American Society of Anesthesiologists score of III (60%), were never-smokers (63%), and had clinical stage T1 disease (92%). Most procedures were for lesions of moderate complexity (46%). All surgical specimens revealed negative surgical margins (100%), with the most common histology being clear cell carcinoma (63%). Overall, 4/65 (6%) procedures led to any-grade Clavien-Dindo complications and 2/65 (3%) required readmissions. No deaths or local or distant recurrence were observed at a median follow-up of 1.1 years. Overall, we found that SDD is safe and feasible for appropriately selected patients undergoing RAPN, with promising perioperative outcomes and low morbidity rates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Feasibility and clinical outcomes of same-day discharge after robot-assisted partial nephrectomy at an ambulatory surgery center

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月20日

查看全文
  • Ivan Kirche-Duarte,
  • Arie Carneiro,
  • Salvador Jaime-Casas,
  • Oluwatimilehin Okunowo,
  • Anjaney Kothari,
  • Ahmad Imam,
  • Daniel Jiang,
  • Rodrigo A. Fribourg-Liendo,
  • Kelvin Zheng,
  • Kevin G. Chan,
  • Ali Zhumkhawala,
  • Jonathan Yamzon,
  • Wesley Yip,
  • Bertram Yuh,
  • Clayton S. Lau

摘要

Robot-assisted partial nephrectomy (RAPN) enables the management of complex localized renal masses while preserving renal function. However, the adoption of institutionalized same-day discharge (SDD) pathways remains limited. Herein, we report the safety and feasibility of SDD RAPN at an ambulatory surgery center (ASC) at our institution. We performed a retrospective observational study of patients who underwent SDD RAPN at a freestanding ASC at our institution during 2022–2025. Patients were eligible for the SDD pathway if they had a good performance status (ECOG 0–1), localized renal masses amenable to partial resection, reliable post-discharge communication, and travel time < 2 h from their residence to the hospital. A total of 63 patients underwent 65 SDD RAPNs at our ASC during 2022–2025. Patients had a median age at surgery of 62 years (interquartile range 51–71 years), and most were male (73%), non-Hispanic (63%), White (70%), and overweight (54%). Most patients had an American Society of Anesthesiologists score of III (60%), were never-smokers (63%), and had clinical stage T1 disease (92%). Most procedures were for lesions of moderate complexity (46%). All surgical specimens revealed negative surgical margins (100%), with the most common histology being clear cell carcinoma (63%). Overall, 4/65 (6%) procedures led to any-grade Clavien-Dindo complications and 2/65 (3%) required readmissions. No deaths or local or distant recurrence were observed at a median follow-up of 1.1 years. Overall, we found that SDD is safe and feasible for appropriately selected patients undergoing RAPN, with promising perioperative outcomes and low morbidity rates.